Blog: ACCURAY INC : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) – Marketscreener.com

Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Appointment of Chief Accounting Officer

On June 9, 2022, the Board of Directors of Accuray Incorporated (the “Company”)
approved the appointment of Franco Palomba to Chief Accounting Officer and
principal accounting officer of the Company, effective as of June 9, 2022. Mr.
Palomba assumes responsibility as principal accounting officer from Ali Pervaiz,
who will continue his role as the Company’s Chief Financial Officer and
principal financial officer.

Mr. Palomba, 60, joined the Company in June 2022 as Vice President, Chief
Accounting Officer and Controller. Previously, he served as Vice President
Finance – Controller at Ashvattha Therapeutics Inc., a clinical-stage
biopharmaceutical company, from November 2021 through May 2022. Prior to that,
he served as Vice President of Finance and Controller at Genomic Health Inc., a
provider of genomic-based diagnostic tests that was acquired by Exact Sciences
Corporation in 2019, from January 2019 to June 2020. Over his 30 year career,
Mr. Palomba served in several senior finance positions at Varian Medical
Systems, Inc., a radiation oncology treatments and software maker, prior to
joining Genomic Health, Inc., most recently as Senior Vice President – Finance
and Corporate Treasurer from January 2012 through April 2018. Mr. Palomba began
his career in finance and accounting as a Financial Audit Associate at
PricewaterhouseCoopers LLP. Mr. Palomba received an M.B.A. from Notre Dame de
Namur University and a B.S. in Accounting from Cal State East Bay.

In connection with his appointment, Mr. Palomba entered into the Company’s
standard indemnification agreement. Mr. Palomba did not receive any additional
compensation in connection with his appointment. Mr. Palomba has no family
relationships or related party transactions with the Company that would require
disclosure under Items 401(d) and 404(a) of Regulation S-K in connection with
his appointment.



Item 7.01. Regulation FD.

On June 15, 2022, the Company issued a press release announcing Mr. Palomba’s
appointment. The press release is furnished as Exhibit 99.1 to this Current
Report on Form 8-K.

The information contained in this Item 7.01 disclosure, including Exhibit 99.1,
is furnished pursuant to Item 7.01 and shall not be deemed to be “filed” for the
purposes of Section 18 of the Exchange Act or otherwise subject to the
liabilities of that Section, nor shall it be incorporated by reference into a
filing under the Securities Act or the Exchange Act, except as shall be
expressly set forth by specific reference in such a filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit No. Description
99.1 Press Release dated June 15, 2022, titled “Accuray Appoints Franco N.
Palomba as VP, Chief Accounting Officer & Controller”
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
——————————————————————————–

© Edgar Online, source Glimpses

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s